A carregar...
Denosumab in Giant Cell Tumor of Bone: Current Status and Pitfalls
Denosumab is a monoclonal antibody against RANK ligand for treatment of giant cell tumor of bone (GCTB). Clinical trials and case series have demonstrated that denosumab is relevant to beneficial tumor response and surgical down-staging in patients of GCTB. However, these trials or case series have...
Na minha lista:
| Publicado no: | Front Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7567019/ https://ncbi.nlm.nih.gov/pubmed/33123484 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.580605 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|